BackLegend Biotech Overview

Legend Biotech Operating Income

Operating Income for LEGN.

Quarterly Operating Income

$-47039844.00
7.12% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-132235739.00
20.82% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)